Clinical trial

The Myocet/Lapatinib Study. ICORG 10-03, V5

NCT01495884

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2015-10-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Her2 Positive Metastatic Breast Cancerunresolved

Interventions

non-pegylated liposomal doxorubicon (Myocet™)DRUG

Lapatinib (Tyverb™)DRUG

Sponsors & collaborators

Cancer Trials Irelandlead sponsor

Mapped research locations

DublinIreland5

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01495884 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.